ALX ONCOLOGY HOLDINGS INC·4

Jan 23, 6:07 PM ET

Lettmann Jason 4

4 · ALX ONCOLOGY HOLDINGS INC · Filed Jan 23, 2025

Insider Transaction Report

Form 4
Period: 2025-01-21
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-01-21+478,000478,000 total
    Exercise: $1.65Exp: 2035-01-20Common Stock (478,000 underlying)
Footnotes (1)
  • [F1]Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025.

Documents

2 files